Details for Patent: 7,901,385

Which drugs does patent 7,901,385 protect, and when does it expire?

Patent 7,901,385 protects SUMAVEL DOSEPRO and is included in one NDA.

This patent has nine patent family members in eight countries.

Summary for Patent: 7,901,385

Title:	Casing
Abstract:	A casing (50) for an injection device (10) of the type having a safety device which prevents operation of the device (10), incorporating an actuator means (56) by which the safety means of the device (10) can be actuated to allow operation of the device (10). Also a casing (50) for a medicament container having an opening closed prior to use by a break-off tip (135), having relatively moveable first and second casing parts (51, 52), which on relative movement apply a breaking force to the break-off tip (135). A preferred embodiment includes both such features.
Inventor(s):	Anderson; Gregor John McLennan (Ware, GB), Mitchell; John (London, GB)
Assignee:	Zogenix, Inc. (Emeryville, CA)
Application Number:	10/506,959
Patent Claim Types: see list of patent claims	Use; Device; Dosage form;

Drugs Protected by US Patent 7,901,385

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Endo Ventures Ltd	SUMAVEL DOSEPRO	sumatriptan succinate	INJECTABLE;SUBCUTANEOUS	022239-001	Jul 15, 2009		DISCN	Yes	No			Y

Foreign Priority and PCT Information for Patent: 7,901,385

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0206560.5	Mar 20, 2002

PCT Information
PCT Filed	March 18, 2003	PCT Application Number:	PCT/EP03/02876
PCT Publication Date:	September 25, 2003	PCT Publication Number:	WO03/077973

International Family Members for US Patent 7,901,385

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2003219086
Canada	2479316
Germany	60315429
European Patent Office	1487517